Skip to Content
🌐Ship toSelect country

Neuramis Volume Lidocaine - 1 x 1ml

Neuramis Volume Lidocaine is the highest-viscosity product in Medytox's SHAPE-technology Neuramis range, formulated with 20mg/ml hyaluronic acid and 0.3% lidocaine for deep facial augmentation and contouring. It is designed for deep dermal and subcutaneous injection to restore volume and structure in areas such as the cheeks, chin and nasolabial folds, offering high elasticity (G′ ≥200 Pa) and cohesiveness for natural-looking, long-lasting results (reported 6-9 months). For use by licensed, trained medical professionals only.

35.95 € 35.95 €
  • Brand
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Neauvia
SKU A14201 Share
Treatment Areas CheeksChinFace
Tags Cross-Linked Hyaluronic AcidHyaluronic AcidLidocaineVolumizer

Neuramis Volume is a firm, high-viscosity formulation within the Neuramis range, designed for facial volumising and contouring in areas such as the cheeks and chin. Its cohesive cross-linked hyaluronic acid gel is intended to provide strong lifting support for a natural-looking result, and it is pre-mixed with lidocaine for injection comfort.

CONCENTRATION

  • Cross-linked hyaluronic acid, high viscosity
  • Lidocaine hydrochloride

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 12-15 months.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Chin volumising

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Neuramis Volume is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin